UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF l934
 
ADMA Biologics, Inc.
 
(Exact name of Registrant as specified in its charter)
 
     
Delaware
 
56-2590442
(State of incorporation
or organization)
 
(I.R.S. Employer
Identification No.)
 
         
465 State Route 17
Ramsey, New Jersey
 
07446-2012
(Address of principal executive offices)
 
(Zip Code)
 
Securities to be registered pursuant to Section 12(b) of the Act:
 
     
Title of each class
to be so registered
  
Name of each exchange on which
each class is to be registered
   
Common Stock, par value $0.0001 per share
 
  
The NASDAQ Stock Market LLC
 
 
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box.     x
 
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box.     ¨
 
Securities Act registration statement file number to which this form relates: 333-186579
 
Securities to be registered pursuant to Section 12(g) of the Act:
 
None
(Title of Class)
 
 
 
 
 
Item 1.
Description of Registrant’s Securities to be Registered.
 
The description of the Registrant’s common stock, par value $0.0001 per share, to be registered hereunder set forth under the caption “Description of Capital Stock” in the Registrant’s Registration Statement on Form S-1 (File No. 333-186579) as originally filed with the Securities and Exchange Commission on February 11, 2013, including any subsequent amendments thereto (the “ Form S-1 ”), and in the prospectus filed by the Registrant pursuant to Rule 424(b) of the Securities Act of 1933, which prospectus constitutes a part of the Form S-1, is hereby incorporated by reference in response to this item.
 
Item 2.
Exhibits.
 
In accordance with the “Instructions as to Exhibits” with respect to Form 8-A, no exhibits are required to be filed as part of this registration statement because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934.
 
 
 
 
 
SIGNATURE
 
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.
 
Dated: November 5, 2014
 
 
ADMA BIOLOGICS, INC.
 
       
    /s/ Adam S. Grossman  
   
By: Adam S. Grossman
 
   
Title: President and CEO